Astellas Pharma Inc.:企業の戦略・SWOT・財務情報

【英語タイトル】Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(DATA904C5811)・商品コード:DATA904C5811
・発行会社(調査会社):MarketLine
・発行日:2018年10月
・ページ数:58
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Astellas Pharma Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Astellas Pharma Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Astellas Pharma Inc. (Astellas or ‘the company’) is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company classifies its business into single operating segment: Pharmaceuticals. It manufactures prescription drugs in therapeutic areas of urology, oncology, immunology, nephrology, muscle diseases, ophthalmology, and neuroscience. The company operates in Japan, other Asian countries, the Americas, Europe, Middle East, and Africa (EMEA), and Oceania. It is headquartered in Tokyo, Japan.

Scope

- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
- Intelligence on Astellas Pharma Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Astellas Pharma Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Astellas Pharma Inc.: Company Overview 9
Astellas Pharma Inc.: Overview and Key Facts 9
Astellas Pharma Inc.: Overview 9
Astellas Pharma Inc.: Key Facts 9
Astellas Pharma Inc.: Key Employees 11
Astellas Pharma Inc.: Key Employee Biographies 13
Astellas Pharma Inc.: Major Products and Services 15
Astellas Pharma Inc.: Company History 16
Astellas Pharma Inc.: Management Statement 26
Astellas Pharma Inc.: Locations and Subsidiaries 29
Astellas Pharma Inc.: Key Competitors 30
Astellas Pharma Inc.: Company Analysis 31
Astellas Pharma Inc.: Business Description 31
Astellas Pharma Inc.: SWOT Analysis 32
Astellas Pharma Inc.: SWOT Overview 32
Astellas Pharma Inc.: Strengths 32
Astellas Pharma Inc.: Weaknesses 34
Astellas Pharma Inc.: Opportunities 34
Astellas Pharma Inc.: Threats 36
Astellas Pharma Inc.: Corporate Financial Deals Activity 38
Astellas Pharma Inc.: Financial Deals Overview 38
Astellas Pharma Inc.: Targets and Partners 40
Astellas Pharma Inc.: Top Deals 2014 – 2018YTD* 42
Astellas Pharma Inc.: Advisors 43
Astellas Pharma Inc.: Top Legal Advisors 43
Astellas Pharma Inc.: Top Financial Advisors 43
Astellas Pharma Inc.: Mergers and Acquisitions 44
Astellas Pharma Inc.: Corporate Venturing 45
Astellas Pharma Inc.: Partnership 46
Astellas Pharma Inc.: Divestments 47
Astellas Pharma Inc.: Recent Developments 48
Astellas Pharma Inc.: News and Events Summary 48
Astellas Pharma Inc.: Corporate Governance 51
Astellas Pharma Inc.: Corporate Social Responsibility 51
Astellas Pharma Inc.: Financial Performance 52
Astellas Pharma Inc.: Market Developments 52
Astellas Pharma Inc.: Red Flags/Distress Signals 53
Astellas Pharma Inc.: Regulatory and Legal Events 53
Astellas Pharma Inc.: Research & Development 53
Astellas Pharma Inc.: Strategy and Operations 55
Appendix 56
Contact Us 56
Methodology 56
About MarketLine 57

List of Tables
Table 1: Astellas Pharma Inc.: Key Facts
Table 2: Astellas Pharma Inc.: Key Employees
Table 3: Astellas Pharma Inc.: Company History
Table 4: Astellas Pharma Inc.: Locations and Subsidiaries
Table 5: Astellas Pharma Inc.: Key Competitors
Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Astellas Pharma Inc.: M&A Activity by Geography (TTM*)
Table 8: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Table 10: Astellas Pharma Inc.: Targets and Partners
Table 11: Astellas Pharma Inc.: Top Deals 2014 - 2018YTD*
Table 12: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
Table 13: Astellas Pharma Inc.: Financial Advisor Ranking by Value (US$m)
Table 14: Astellas Pharma Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: Astellas Pharma Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 16: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 17: Astellas Pharma Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 18: Astellas Pharma Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: Astellas Pharma Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: Astellas Pharma Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: Astellas Pharma Inc.: News and Events Summary
Table 22: Astellas Pharma Inc.: Corporate Governance
Table 23: Astellas Pharma Inc.: Corporate Social Responsibility
Table 24: Astellas Pharma Inc.: Financial Performance
Table 25: Astellas Pharma Inc.: Market Developments
Table 26: Astellas Pharma Inc.: Red Flags/Distress Signals
Table 27: Astellas Pharma Inc.: Regulatory and Legal Events
Table 28: Astellas Pharma Inc.: Research & Development
Table 29: Astellas Pharma Inc.: Strategy and Operations

List of Figures
Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Astellas Pharma Inc.: M&A Activity by Geography (TTM*)
Figure 3: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Astellas Pharma Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Astellas Pharma Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Astellas Pharma Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Astellas Pharma Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Astellas Pharma Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Astellas Pharma Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★調査レポート[Astellas Pharma Inc.:企業の戦略・SWOT・財務情報] (コード:DATA904C5811)販売に関する免責事項を必ずご確認ください。
★調査レポート[Astellas Pharma Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆